-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Addus HomeCare, Raises Price Target to $160

Benzinga·11/06/2026 00:10:21
Listen to the news
UBS analyst A.J. Rice maintains Addus HomeCare (NASDAQ:ADUS) with a Buy and raises the price target from $145 to $160.